A new Alzheimer’s blood-test model may help researchers estimate when symptoms begin, but it is not ready for routine use or screening in healthy adults.
An NIH-backed 20-year follow-up links one specific speed-training program—not all brain games—to fewer dementia diagnoses. Here’s what it means.
New Alzheimer’s blood tests are becoming part of clinical care in the United States, but they are not simple screening tools for anyone worried about forgetfulness. Here’s what the FDA cleared, what specialists recommend, and what families should ask before treating a blood result as proof of Alzheimer’s disease.
A new Nature Medicine study suggests a blood-based model may help estimate when Alzheimer’s symptoms could begin, but the research is not a consumer screening test. Here’s what the study actually found, what U.S. patients can access now, and why memory symptoms still need a full medical workup.
FDA-approved anti-amyloid drugs like lecanemab can modestly slow early Alzheimer’s disease—but they are not cures. Here’s who qualifies, what the clinical trials showed, the real risks, and how Medicare coverage works in 2026.
Trauma is a leading cause of death and disability in the United States. Here’s what recent public health guidance and medical evidence say about injury risks, recovery, and when to seek care.
Stroke remains a leading cause of death and long-term disability in the United States. Here’s what the most recent CDC data shows, who is at highest risk, and what everyday prevention steps can lower your chances.
Headaches are common, but not all are the same. Here’s what U.S. health experts say about types of headaches, warning signs, treatment options, and when to seek medical care.
New and ongoing guidance from U.S. public health agencies highlights practical steps people can take to lower their risk of stroke, dementia, and other brain-related conditions. Here’s what matters most for everyday life.
Dementia is not an inevitable part of aging. Here’s what major public health agencies and medical journals say about protecting brain health—and what it means for you and your family.
Dementia affects millions of Americans, and new treatments and prevention research continue to evolve. Here’s what families should understand about early signs, risk factors, available medications, and what remains uncertain.
Most headaches are not dangerous, but some need medical attention. Here’s how to tell the difference, what current guidance says about treatment, and when to see a doctor.
Stroke remains a leading cause of death and long-term disability in the United States. Here’s what the latest public health guidance says about symptoms, treatment timing, risk factors, and practical prevention steps.
Ultra-processed foods (UPFs) such as chips, sodas, and processed meats are increasingly under scrutiny due to their high concentrations of microplastics, which have been linked to mental health concerns. Recent studies in Brain Medicine reveal that these microplastics can cross the blood-brain barrier…
End of content
End of content
